Recent

% | $
Quotes you view appear here for quick access.

Opexa Therapeutics, Inc. (OPXA) Message Board

  • rrtzrealmd rrtzrealmd Feb 5, 2013 10:02 AM Flag

    HAW!!!...gotta love it!...

    ..."Potential payments to Opexa from the option and license agreement could total $225 million based upon the successful development and commercialization of Tcelna for MS."...HAW!!!...

    ...that's rich!!...of course, OPXA only gets 5 million dollars initially to conduct their trial...

    ...and given that OPXA was begging to get even $650,000 a couple of weeks ago just to stay listed, you figure that they don't have very deep pockets...

    ...and in practcial terms, 5 million dollars will be barely enough to pay management salaries for a few more months, much less pay for a phase 2 trial...

    ...and given that Tovaxin...now renamed "Tcelna" -- that is much more hip, don't you thin...HAW!!!...

    ...anyway, as I was saying, given the past overwhelming successes of tovaxin -- does anyone smell the scent of sarcasm here -- I really don't think OPXA anything beyond that 5 million...

    ...but at least management gets to keep their fat salaries, benefits, bonuses, and perks for a little while longer...and after all, when you're a biotech, that's what really counts -- right?...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OPXA
0.390.00(+0.15%)May 22 3:57 PMEDT